Showing results (111-120 of 552) with videos related to
Sort By:
Pageof 56
Molecules (Basel, Switzerland)|March 8, 2017
The Pharmaceutical Industry in 2016. An Analysis of FDA Drug Approvals from a Perspective of the Molecule TypeBeatriz G de la Torre, Fernando AlbericioMolecules (Basel, Switzerland)|February 13, 2025
The Pharmaceutical Industry in 2024: An Analysis of the FDA Drug Approvals from the Perspective of MoleculesBeatriz G de la Torre, Fernando AlbericioMolecules (Basel, Switzerland)|March 3, 2018
The Pharmaceutical Industry in 2017. An Analysis of FDA Drug Approvals from the Perspective of MoleculesBeatriz G de la Torre, Fernando AlbericioOrganic Letters|August 2, 2003
Fmoc solid-phase synthesis of peptide thioesters by masking as trithioortho estersJesper Brask, Fernando Albericio, Knud J JensenMolecules (Basel, Switzerland)|March 1, 2019
The Pharmaceutical Industry in 2018. An Analysis of FDA Drug Approvals from the Perspective of MoleculesBeatriz G de la Torre, Fernando AlbericioJournal of Combinatorial Chemistry|March 17, 2007
Solid-phase synthesis of sulfamate peptidomimeticsJosep Farrera-Sinfreu, Fernando Albericio, Miriam RoyoMolecules (Basel, Switzerland)|January 28, 2021
The Pharmaceutical Industry in 2020. An Analysis of FDA Drug Approvals from the Perspective of MoleculesBeatriz G de la Torre, Fernando AlbericioMolecules (Basel, Switzerland)|February 13, 2026
The Pharmaceutical Industry in 2025: An Analysis of FDA Drug Approvals from the Perspective of MoleculesBeatriz G de la Torre, Fernando AlbericioMolecules (Basel, Switzerland)|February 10, 2024
The Pharmaceutical Industry in 2023: An Analysis of FDA Drug Approvals from the Perspective of MoleculesBeatriz G de la Torre, Fernando AlbericioMolecules (Basel, Switzerland)|February 15, 2022
The Pharmaceutical Industry in 2021. An Analysis of FDA Drug Approvals from the Perspective of MoleculesBeatriz G de la Torre, Fernando AlbericioPageof 56